10x Genomics (TXG) Cash from Investing Activities Growth (1y) (2019 - 2026)

10x Genomics (TXG) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn -645.99%
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn 3,189.55%
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn 13.87%
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn 325.40%
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn 30.74%
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn 1.75%
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn -276.75%
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn 663.79%
9 Privia Health 3.10 Bn 2.68 Bn - -
10 Omnicell 1.89 Bn 1.65 Bn 140.36 Mn -0.81%

Historic Data

Download Data
DateValue
Mar 31, 2026 30.74%
Dec 31, 2025 96.50%
Sep 30, 2025 -143.26%
Jun 30, 2025 -107.86%
Mar 31, 2025 -117.80%
Dec 31, 2024 -493.89%
Sep 30, 2024 -173.84%
Jun 30, 2024 367.75%
Mar 31, 2024 -91.14%
Dec 31, 2023 139.49%
Sep 30, 2023 115.02%
Jun 30, 2023 83.79%
Mar 31, 2023 146.57%
Dec 31, 2022 -20.11%
Sep 30, 2022 -61.32%
Jun 30, 2022 -88.96%
Mar 31, 2022 -481.19%
Dec 31, 2021 -24.04%
Sep 30, 2021 -1,444.05%
Jun 30, 2021 -116.17%